📊 DXR Key Takeaways
Is Daxor Corp. (DXR) a Good Investment?
Daxor Corp exhibits severe operational distress with negative profitability across all metrics and rapidly deteriorating fundamentals. The company generated only $1.4M in revenue while burning $6.5M in operating cash flow, indicating an unsustainable business model. With minimal cash reserves ($59.6K) relative to operating losses and outdated financial data (2011), the company faces imminent liquidity crisis without dramatic operational improvement.
DAXOR CORP's fundamentals appear very weak based on the provided SEC data, with declining revenue, deeply negative operating and net margins, and substantial cash burn relative to a very small revenue base. While the balance sheet shows positive equity, no long-term debt, and acceptable short-term liquidity, the combination of severe unprofitability, negative free cash flow, and minimal cash on hand suggests poor financial quality and elevated operating risk.
Why Buy Daxor Corp. Stock? DXR Key Strengths
- Positive current ratio of 1.66x suggests short-term liquidity adequate for immediate obligations
- Zero long-term debt eliminates financial leverage risk
- Gross margin of 54.9% indicates viable core product economics before operating expenses
- Positive gross margin indicates the core product still generates gross profit
- No long-term debt reduces financial leverage risk
- Current and quick ratios above 1.6x suggest near-term obligations were not immediately distressed
DXR Stock Risks: Daxor Corp. Investment Risks
- Catastrophic operating losses (-$5.8M) with negative 400% operating margin
- Severe cash burn of -$6.5M operating cash flow against trivial $59.6K cash position creates imminent solvency risk
- Revenue collapse of -8.4% YoY combined with widening losses demonstrates inability to achieve scale or cost control
- Deeply negative return metrics (ROE -19.8%, ROA -8.4%) indicate value destruction
- Data freshness from 2011 raises questions about current operational status and potential delisting
- Operating and net losses are extremely large relative to revenue, indicating an unsustainable cost structure
- Negative operating cash flow and free cash flow show the business is consuming cash rather than generating it
- Cash balance is very low, limiting flexibility if losses continue
Key Metrics to Watch
- Revenue stabilization and growth trajectory
- Path to operating profitability and positive operating cash flow
- Cash burn rate and runway until liquidity exhaustion
- Revenue growth and operating expense discipline
- Operating cash flow and ending cash balance
Daxor Corp. (DXR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Daxor Corp. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
DXR Profit Margin, ROE & Profitability Analysis
DXR vs Market Sector: How Daxor Corp. Compares
How Daxor Corp. compares to Market sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Daxor Corp. Stock Overvalued? DXR Valuation Analysis 2026
Based on fundamental analysis, Daxor Corp. has mixed fundamental signals relative to the Market sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Daxor Corp. Balance Sheet: DXR Debt, Cash & Liquidity
DXR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Daxor Corp.'s revenue has remained relatively flat over the 5-year period, with a 0% decline.
DXR Revenue Growth, EPS Growth & YoY Performance
DXR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2011 | $340.9K | $2.4M | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Daxor Corp. Dividends, Buybacks & Capital Allocation
DXR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Daxor Corp. (CIK: 0000027367)
📋 Recent SEC Filings
❓ Frequently Asked Questions about DXR
What is the AI rating for DXR?
Daxor Corp. (DXR) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 94% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are DXR's key strengths?
Claude: Positive current ratio of 1.66x suggests short-term liquidity adequate for immediate obligations. Zero long-term debt eliminates financial leverage risk. ChatGPT: Positive gross margin indicates the core product still generates gross profit. No long-term debt reduces financial leverage risk.
What are the risks of investing in DXR?
Claude: Catastrophic operating losses (-$5.8M) with negative 400% operating margin. Severe cash burn of -$6.5M operating cash flow against trivial $59.6K cash position creates imminent solvency risk. ChatGPT: Operating and net losses are extremely large relative to revenue, indicating an unsustainable cost structure. Negative operating cash flow and free cash flow show the business is consuming cash rather than generating it.
What is DXR's revenue and growth?
Daxor Corp. reported revenue of $1.4M.
Does DXR pay dividends?
Daxor Corp. pays dividends, with $1.1M distributed to shareholders in the trailing twelve months.
Where can I find DXR SEC filings?
Official SEC filings for Daxor Corp. (CIK: 0000027367) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DXR's EPS?
Daxor Corp. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is DXR a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Daxor Corp. has a STRONG SELL rating with 94% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is DXR stock overvalued or undervalued?
Valuation metrics for DXR: ROE of -19.8% (sector avg: 15%), net margin of -496.8% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy DXR stock in 2026?
Our dual AI analysis gives Daxor Corp. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is DXR's free cash flow?
Daxor Corp.'s operating cash flow is $-6.5M, with capital expenditures of $123.2K. FCF margin is -458.5%.
How does DXR compare to other Market stocks?
Vs Default sector averages: Net margin -496.8% (avg: 12%), ROE -19.8% (avg: 15%), current ratio 1.66 (avg: 1.8).